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thesia, and 16 controls.Pre-operative radiographs of the femorotibial
joints were performed to exclude animals with pathology. Rabbits
were anesthetized and ACLT performed through a medial parapatellar
incision. Serumwas collected at -14 (baseline), 7, 14, 28, 42, 56, 70 and
84 days post-ACLT and aliquots were frozen at -20C until analysis.
Eight mL of the diluted thawed serum (1:1 in 4% KSCN) was placed in 5
mm diameter circular wells on an adhesive-masked silicon micro-
plate. Once dry, the microplate was mounted in a Fourier-transform
infrared spectrometer (FTIR; Tensor 37, Bruker Optics, Milton, Canada)
for the acquisition of IR absorbance spectra (400-4000 cm-1). For
each acquisition, 512 interferograms were signal averaged and Fourier
transformed to generate a spectrum with a nominal resolution of 4
cm-1. Spectra generated from each sample were averaged, differ-
entiated and smoothed to resolve and enhance weak spectral features
and to remove variation in baselines, using spectral manipulation
software. Following preprocessing, partial least squares discriminant
analysis (PLS-DA) was applied to the IR spectra at each time point
using script written in MatLab®. Variables contributing to the sepa-
ration of groups were selected using t-statistic, PLS weights and
regression coefﬁcients. Monte-Carlo methods were employed to
determine the empirical signiﬁcance of variables for separating
groups, by randomly permuting the class membership 5000 times to
obtain null distributions, and comparing the observed statistic for
each variable with the null distribution. The PLS-DA optimal model
was considered valid for Q2 (one minus the ratio of the prediction
error sum of squares over the total sum of squares of the response
vector) values signiﬁcant at P < 0.05.
Results: Infrared spectroscopic spectra combined with a PLS-DA clas-
siﬁcation strategy, generated IR-based serum biomarker proﬁles that
successfully discriminated between ACLT and control rabbits. Differ-
ences were signiﬁcant at 7, 14, 28, 42, 56, 70 and 84 days post-ACLT. The
distribution of t-statistic, PLS weights and regression coefﬁcients varied
signiﬁcantly between time points, indicating the potential of the
approach for monitoring the progression of osteoarthritis.
Conclusions: “Multiplexed” approaches have emerged in recent years
for the identiﬁcation and veriﬁcation of novel OA biomarkers,
employing genomic, proteomic and metabolomic tools. Although IR
spectroscopy has been used for rheumatoid arthritis, this study is the
ﬁrst to employ IR spectroscopy and PLS-DA to screen serum for a bio-
marker signature reﬂective of OA, encompassing both known and
unknown markers of disease. The ideal biomarker approach should be
rapidly and simply performed, yield accurate results, identify pro-
gression,differentiate between early and late stages of disease, and use
small volumes of easily accessible body ﬂuid. The method described
here achieves many of these ideals with fewer technical and less
expensive infrastructure requirements than others. Nevertheless access
to a larger number of well characterized biological samples is required
for more extensive validation.
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BASELINE FIBULIN3 CONCENTRATIONS ARE ASSOCIATED WITH
INCIDENCE OF CLINICAL KNEE OA AFTER 30 MONTHS IN
OVERWEIGHT AND OBESE WOMEN
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Purpose: Fibuline3 is highly expressed in osteoarthritic cartilage and
inhibits angiogenesis and chondrocyte differentiation. It has been
demonstrated to interact with the tissue inhibitor of metalloprotease
(TIMP)-3, which is a matrix bound inhibitor of matrix metal-
loproteinases (MMPs) and stimulates the expression of TIMP-1 and
TIMP-3, but inhibits the expression and activities of MMP-2, MMP-3,
and MMP-9. In the present study, the association between three Fibu-
lin3 peptides identiﬁed by proteomics and the incidence of radio-
graphic and clinical knee osteoarthritis (OA) in middle-aged overweight
and obese women, free of radiographic and symptomatic knee OA at
baseline was tested.
Methods: Women between 50 and 60 years, with a BMI  27 kg/m2,
free of knee OA were recruited through their general practitioner. At
baseline, physical examination including serum collection was
performed and radiographs and questionnaires on knee complaintswere obtained. Using binary logistic regression, the association
between baseline concentration of Fibulin(Fib)3-1, Fib3-2 and Fib3-3
and incidence of clinical and radiographic knee OA after 30
months of follow-up was tested, adjusting for age, BMI, and other
potential covariates that were identiﬁed in multivariable regression
analyses.
Results: Baseline serum samples and follow-up measurements were
available for 242 women. Mean agewas 55.9 ± 3.2 years, mean BMI was
31.6 ± 3.6 kg/m2 and 70%was postmenopausal. All subjects were free of
clinical and radiographic knee OA at baseline, but 24% had a unilateral
K&L score of 1 and 33% bilaterally. Mild symptoms were present in 24%
and 17% of the subjects, uni- and bilaterally respectively. Baseline
concentrations of all Fib3 fragments were log-transformed for a normal
distribution and z-transformed for uniformity reasons. Correlation
coefﬁcients for the baseline concentrations of the three Fib3 fragments
ranged from 0.13 to 0.58. Neither of the concentrations of the three Fib3
fragments were associated with incidence of medial or lateral joint
space narrowing  1.0 mm. or incidence of K&L grade 2. All three Fib3
fragments were associated with incidence of the clinical and radio-
graphic ACR-criteria and Fib3-1 and Fib3-3 also with chronic pain at
follow-up (see ﬁgure). When adjusted for the other Fib3 peptide con-
centrations, only Fib3-1 was signiﬁcantly associated to the incidence of
the ACR criteria (OR 2.5 [1.0-6.2]) and chronic pain at follow-up (OR 2.6
[1.1-5.9]).
Conclusions: Baseline Fibulin3 concentrations are associated to the
incidence of clinical knee OA amongmiddle-aged overweight and obese
women. Therewith, they meet the criteria of a prognostic biomarker
according to the BIPED biomarker classiﬁcation for OA. Further vali-
dation of the Fibulin3 fragments seems warranted in order to better
distinguish subgroups of individuals at increased risk for knee OA
development.
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DETECTION OF CTXII IN THE RAT KNEE VIA MAGNETIC BIOMARKER
CAPTURE
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Gainesville, FL, USA
Purpose: Osteoarthritis (OA) biomarker development often begins
with rodent models; however, methods to recover OA biomarkers from
rodent joints are not ideal. In large human joints, synovial ﬂuid can be
aspirated for biomarker analysis, but synovial ﬂuid aspiration from a
rat knee is limited by complex joint geometries and small ﬂuid vol-
umes. Instead, saline is often used to lavage synovial ﬂuid from the
joint, but lavage has limitations, including: 1) Lavage ﬂuids dilute
biomarker concentrations; 2) Mixing saline with highly viscous
synovial ﬂuid is not trivial and verifying ﬂuids are well-mixed prior to
removal from the rodent knee is practically impossible; and 3) Esti-
mation of joint-level biomarker concentrations is susceptible to joint
effusion. To address these limitations, our group has developed a
magnetic nanoparticle-based technology to collect OA biomarkers
from synovial ﬂuid in situ, termed magnetic capture. Using polymeric
particles that contain superparamagnetic iron oxide nanoparticles
(SPIONs) and are surface-functionalized with a targeting molecule, OA
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of biomarker per particle following the magnetic capture procedure
can be used to estimate total biomarker levels within the joint, a
measure that is less susceptible to the effects of effusion. The purpose
of this study is to demonstrate the ability of magnetic capture to
measure joint-levels of c-telopeptide of type II collagen (CTXII) levels
in a rat OA model.
Methods: Using EDC cross-linking, antibodies against CTXII were
conjugated to carboxyl groups on the surface of 780 nm diameter
polystyrene particles that contained 8.5 nm diameter SPIONs, here-
after referred to as anti-CTXII particles. To assess magnetic capture in
a rat knee, 22 Sprague-Dawley rats (90 days old, male) were acquired.
First, 6 naive rats received an intra-articular injection of 180, 360, or
720 million anti-CTXII particles (n¼4 per knees per group). Next, 8
rats received an intra-articular injection of monoiodoacetate (MIA, 3
mg in 25 mL of saline) with OA allowed to develop over 30 days; the
remaining 8 rats served as age-matched naïve controls for the MIA
animals. For MIA animals and their age-matched naïve controls, 720
million anti-CTXII particles were injected into the knee joint. For all
experiments, injected anti-CTXII particles were allowed to incubate
in the joint for 2 hrs prior to collection. Then, a 1 mm diameter by 1
mm length NdFeB magnet attached to the end of a steel rod was
inserted into the joint space through a 16 gauge catheter. Particles
were collected on the magnet for 10 minutes. Then, the magnet was
removed and washed to isolate particles. Collected particles were
heated to 85C for 3 min, followed by quantiﬁcation of collected
particles and CTXII. CTXII levels in the joint were estimated by
multiplying the ratio of biomarker to particles by the total number of
particles injected. Serum was also collected for CTXII analysis. All
studies were conducted under IACUC-approved protocols. Since the
purpose of this study was to demonstrate feasibility, all magnetic
capture procedures were conducted immediately after humane
euthanasia.
Results:Magnetic capture was able to recover detectable levels of CTXII
from all rat knees. Moreover, estimates of total CTXII levels in the joint
were independent from the number of particles injected (Figure 1a);
thus, a stable estimate of CTXII can be obtained in the rat knee using
post-mortem magnetic capture.
Using magnetic capture, elevated levels of CTXII were detected in
OA-affected joints relative to both contralateral knee and naïve
controls (Figure 1b), while CTXII concentrations in the serum of these
same animals did not yield signiﬁcant differences between MIA-
injected and age-matched naïve control animals (Figure 1c). These
data demonstrate the utility of biomarker assessments in the OA-
affected knee and the ability of magnetic capture to facilitate these
analyses.
Conclusions: Using magnetic capture, signiﬁcant changes in total
CTXII levels were detected in MIA-injected joints using 8 rats per
group. This demonstrates a marked improvement over published lav-
age techniques for the MIA model, where 19-20 animals per group are
often needed to identify signiﬁcant elevations in CTXII concentration
post-lavage. Thus combined, these data demonstrate the feasibility,
stability, and utility of magnetic capture for OA biomarker analysis in
the rat knee.103
QUANTITATIVE PROTEOMICS REVEALS PUTATIVE BIOMARKERS IN
PRE-RADIOLOGICAL OSTEOARTHRITIS
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Purpose: In this studywe have identiﬁed proteins differentially abundant
in the serum of Osteoarthritis (OA) patients comparing four different
progressive pathological grades using mass spectrometry and iTRAQ
technique for relative quantiﬁcation. Ourﬁnal aim is to establish a panel of
biomarkers useful to predict thepathology inpre-radiological stages (early
Osteoarthritis biomarkers), but also for its handling and the developing of
trials of treatment in radiological stages (late Osteoarthritis biomarkers).
Methods: 15 individual samples for each condition (OA Grade 0, pre-
radiological stage Grade I, and radiological stage grades II-III and IV)
were pooled in three groups with the aim of reducing the contribution
of individual extreme values. After enrichment in the low-abundant
protein fraction, the pooled samples were subjected to in-solution
digestion, followed by iTRAQ labelling following manufacturer
instructions and Reverse Phase peptide separation in a LC system
(Agilent 1200). Fractions were again separated in a nanoLC system
(Tempo, Eksigent) automatically deposited on a MALDI plate and ana-
lyzed by MSMS in a 4800 MALDI-TOF/TOF system (ABSciex). Relative
quantitative analysis was done using ProteinPilot software (ABSciex)
and modulated proteins were analyzed with String 9.0 software.
Results:We have detected two big sets of serum proteins modulated in
the early pre-radiological OA process. Serum levels of apolipoproteins
are altered when comparing Grade I vs. Grade 0. Speciﬁcally, apolipo-
protein E and apolipoprotein B-100, that mediates the binding, inter-
nalization, and catabolism of lipoprotein particles are accumulated in
Grade I samples. Furthermore, up to six components of the comple-
ment, a group of proteins involved in immune response and inﬂam-
mation are decreased in serum in early OA grades. Among them,
complement component 5 -C5-, that have been recently identiﬁed as
key player of the OA process, is much less abundant in any OA grade in
comparison to Grade 0. Proteins previously described as putative bio-
markers by our group and others, like histidine-rich glycoprotein, gel-
solin and decorin, are also modulated in our study, but at later
radiological stages -Grade II/III and Grade IV vs. Grade I and Grade 0-.
Conclusions: Our results indicate that early pathological grades of the OA
process are linked to an imbalance in the metabolism and, speciﬁcally, in
the lipid metabolism. Altered serum levels of apo-lipoproteins could be
used, in combinationwith other “dry” biomarkers, as an indicator for early
OA process and to detect the pathology in pre-radiological stages. Fur-
thermore, the lower serum levels in the OA grades detected for the com-
plement component 5 -C5-, strongly support recent in vivo data indicating
that a decrease of this protein is linked to the development of the disease.104
STATUS OF OXIDATIVE STRESS BIOMARKERS IN OSTEOARTHRITIS
PATIENTS IN NORTH INDIAN POPULATION
S. Srivastava y, A.K. Saksena y, S. Khattri y, S. Kumar z, R.S. Dagur x. yDept.
of Pharmacology& Therapeutics, King George's Med. Univ., Lucknow, India;
zDept. of Orthopedic Surgery, King George's Med. Univ., Lucknow, India;
xAdvancedMolecular Sci. Res. Ctr., King George's Med. Univ., Lucknow, India
Purpose: Osteoarthritis (OA) is the most common type of arthritis in
which there is membrane / cartilage destruction leading to bone
